ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Hatfield, Kennedy Bill would Establish Panel for Clinical Research

February 16, 1996

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

NCI Clinical Alert Urges Patients To Seek Care From Specialists.

January 20, 2006

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991